-
Johnson, DW, Pascoe, EM, Badve, SV, Dalziel, K, Cass, A, Clarke, P, Ferrari, P, McDonald, SP, Morrish, AT, Pedagogos, E, et al. A Randomized, Placebo-Controlled Trial of Pentoxifylline on Erythropoiesis-Stimulating Agent Hyporesponsiveness in Anemic Patients With CKD: The Handling Erythropoietin Resistance With Oxpentifylline (HERO) Trial.
American Journal of Kidney Diseases
65(1)
:
49 -57
2014
view publication
-
Segal, L, Dalziel, K, Mortimer, D. Fixing the game: are between‐silo differences in funding arrangements handicapping some interventions and giving others a head‐start?.
Health Economics
19(4)
:
449 -465
2009
view publication
-
Dalziel, K, Segal, L, Katz, R. Cost-effectiveness of mandatory folate fortification v. other options for the prevention of neural tube defects: results from Australia and New Zealand.
Public Health Nutrition
13(4)
:
566 -578
2009
view publication
-
Segal, L, Dalziel, K, Bolton, T. A work force model to support the adoption of best practice care in chronic diseases – a missing piece in clinical guideline implementation.
Implementation Science
3(1)
:
35
2008
view publication
-
Dalziel, K, Segal, L, Mortimer, D. Review of Australian health economic evaluation – 245 interventions: what can we say about cost effectiveness?.
Cost Effectiveness and Resource Allocation
6(1)
:
9
2008
view publication